blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3796907

EP3796907 - GABAA POSITIVE ALLOSTERIC MODULATOR COMPOUNDS FOR TREATMENT OF ITCH AND/ OR DERMATITIS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.02.2021
Database last updated on 24.08.2024
FormerThe international publication has been made
Status updated on  30.11.2019
Most recent event   Tooltip19.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Neurocycle Therapeutics, Inc.
1 Broadway Fl. 14
Cambridge, Massachusetts 02142 / US
[2021/13]
Inventor(s)01 / TOCZKO, Matthew
1 Broadway Fl. 14
Cambridge, Massachusetts 02142 / US
02 / HUBBS, Jed
1 Broadway Fl. 14
Cambridge, Massachusetts 02142 / US
 [2021/13]
Representative(s)Brand Murray Fuller LLP
50 Eastcastle Street
London W1W 8EA / GB
[2021/13]
Application number, filing date19808207.522.05.2019
[2021/13]
WO2019US33598
Priority number, dateUS201862674726P22.05.2018         Original published format: US 201862674726 P
[2021/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019226820
Date:28.11.2019
Language:EN
[2019/48]
Type: A1 Application with search report 
No.:EP3796907
Date:31.03.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 28.11.2019 takes the place of the publication of the European patent application.
[2021/13]
Search report(s)International search report - published on:US28.11.2019
(Supplementary) European search report - dispatched on:EP01.10.2021
ClassificationIPC:A61K31/437, A61K31/5025, A61P17/04
[2021/44]
CPC:
A61K31/502 (EP,US); A61K31/5025 (EP,US); A61K31/437 (EP,US);
A61K47/26 (EP); A61K47/40 (EP); A61K9/0053 (US);
A61K9/0095 (EP); A61K9/08 (EP); A61K9/2018 (EP);
A61K9/4858 (EP); A61P17/04 (EP,US); A61K9/1075 (EP) (-)
Former IPC [2021/13]A61K31/437, A61K31/5025, A61P17/04, C07D237/28, C07D471/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/13]
TitleGerman:GABAA-POSITIVE ALLOSTERISCHE MODULATORVERBINDUNGEN ZUR BEHANDLUNG VON JUCKEN UND/ODER DERMATITIS[2021/13]
English:GABAA POSITIVE ALLOSTERIC MODULATOR COMPOUNDS FOR TREATMENT OF ITCH AND/ OR DERMATITIS[2021/13]
French:COMPOSÉS MODULATEURS ALLOSTÉRIQUES POSITIFS GABAA POUR LE TRAITEMENT DU PRURIT ET/OU DE LA DERMATITE[2021/13]
Entry into regional phase17.12.2020National basic fee paid 
17.12.2020Search fee paid 
17.12.2020Designation fee(s) paid 
17.12.2020Examination fee paid 
Examination procedure17.12.2020Examination requested  [2021/13]
27.04.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
17.12.2020Renewal fee patent year 03
30.05.2022Renewal fee patent year 04
31.05.2023Renewal fee patent year 05
19.03.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2017129801  (UNIV ZUERICH [CH]) [Y] 1-14 * page 16, line 30 - line 31 * * second paragraph from the bottom; page 3 *;
 [Y]US2018104244  (ERICKSON CRAIG [US], et al) [Y] 1-14* claim 3 *;
 [Y]  - JUCAITE AURELIJA ET AL, "GABAAreceptor occupancy by subtype selective GABAA[alpha]2,3modulators: PET studies in humans", PSYCHOPHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 234, no. 4, doi:10.1007/S00213-016-4506-4, ISSN 0033-3158, (20161224), pages 707 - 716, (20161224), XP036143669 [Y] 1-12 * front page, Abstract *

DOI:   http://dx.doi.org/10.1007/s00213-016-4506-4
International search[A]US8952008  (OMOTO KIYOYUKI [GB], et al) [A] 1-6, 10-14, 29* entire document *;
 [A]US9526718  (LEE DOO HYUN [KR], et al) [A] 1-6, 10-14, 29 * entire document *;
 [Y]WO2017129801  (UNIV ZUERICH [CH]) [Y] 1-6, 10-14, 29 * entire document *;
 [Y]US2018104244  (ERICKSON CRAIG [US], et al) [Y] 1-6, 10-14, 29 * entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.